Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P, Barros-Silva JD, Ribeiro FR, Ramalho-Carvalho J, Jerónimo C, Henrique R, Lind GE, Skotheim RI, Lothe RA, Teixeira MR.
Genes Chromosomes Cancer. 2012 Mar;51(3):240-9. doi: 10.1002/gcc.20948. Epub 2011 Nov 12.
Related citations
PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
Yoshimoto M, Ludkovski O, DeGrace D, Williams JL, Evans A, Sircar K, Bismar TA, Nuin P, Squire JA.
Genes Chromosomes Cancer. 2012 Feb;51(2):149-60. doi: 10.1002/gcc.20939. Epub 2011 Nov 1.
The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.
Porkka KP, Ogg EL, Saramäki OR, Vessella RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M, Kallioniemi OP, Jenster G, Visakorpi T.
Genes Chromosomes Cancer. 2011 Jul;50(7):499-509. doi: 10.1002/gcc.20873. Epub 2011 Mar 31.
Relative 8q gain predicts disease-specific survival irrespective of the TMPRSS2-ERG fusion status in diagnostic biopsies of prostate cancer.
Barros-Silva JD, Ribeiro FR, Rodrigues A, Cruz R, Martins AT, Jerónimo C, Henrique R, Teixeira MR.
Genes Chromosomes Cancer. 2011 Aug;50(8):662-71. doi: 10.1002/gcc.20888. Epub 2011 May 16.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on